AHP955 is specific for the human CD267 cell surface antigen, also known as transmembrane activator and CAML interactor (TACI).
CD267 is a member of the tumour necrosis factor family, which is expressed by B lymphocytes, activated T lymphocytes and myeloma cells. CD267 is a a receptor for BAFF and CD256 (APRIL), and is thought to play an important regulatory role in B-cell homeostasis and autoimmunity.
Application
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visitwww.abdserotec.com/protocols.
Application Name
Yes
No
Not Determined
Suggested Dilution
ELISA
Flow Cytometry
Immunohistology - Frozen
Immunohistology - Paraffin
Immunoprecipitation
Western Blotting
2ug/ml - 5ug/ml
Where this antibody has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the antibody for use in their own system using appropriate negative/positive controls.
Western Blotting
AHP955 detects a band of approximately 32kD in K562 cell lysates
Storage
Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
Shelf Life
18 months from date of despatch.
Antiserum Preparation
Antisera to human CD267 were raised by repeated immunisations of rabbits with highly purified antigen. Purified IgG prepared by affinity chromatography.
京公网安备11010802025653 版权所有：北京逸优科技有限公司
